Evaluation of Immunogenicity of COVID-19 Vaccine in Chinese Population

NCT06763887 | Completed

• 1 other identifier: KY20232379-C-1
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to evaluate the immunogenicity and immune protection of COVID-19, especially the recently prevalent strains, against the background of current immunization in Chinese population

Conditions

COVID

Outcome Measures

Primary Outcomes (1)

• PBMC

  When conducting blood sample analysis, we focus on separating and evaluating in detail the composition and counting of peripheral blood mononuclear cell (PBMC). This process involves identifying and quantifying various types of mononuclear cells in the sample, such as lymphocytes, monocytes, etc. These cells are crucial for understanding an individual's immune status. Through precise separation techniques and advanced cell analysis methods, we are able to obtain accurate and detailed reports on the classification and quantity of mononuclear cells.

  About two and a half years

Study Arms (1)

Observation

Other: No Interventions

Interventions

No Interventions OTHER

No intervention

Observation

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

People infected with COVID-19

You may qualify if:

• He was infected with COVID-19 from November to December 2022;
• Have not been infected with COVID-19 (the subject said that he was not infected and signed the informed consent form);
• Those who agree and sign the informed consent form.

You may not qualify if:

• Missing or incomplete questionnaires that affect research results;
• Individuals with combined dysfunction of important organs such as the heart, liver, and lungs;
• Mental and behavioral abnormalities;
• Intellectual disability;
• Under 18 years old or over 75 years old;
• Low understanding and communication skills.

Sponsors & Collaborators

• Xijing Hospital: lead

Study Sites (1)

The First Affiliated Hospital of Air Force Military Medical University

Xi'an, Shaanxi, 710004, China

Location

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 21, 2024
• First Posted: January 8, 2025
• Study Start: November 15, 2023
• Primary Completion: June 30, 2024
• Study Completion: June 30, 2024
• Last Updated: January 8, 2025

Record last verified: 2024-11

Locations

CN (1)